{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:16:49Z","timestamp":1793121409395,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2016-I2M-02-002"],"award-info":[{"award-number":["2016-I2M-02-002"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09711001-007-002"],"award-info":[{"award-number":["2018ZX09711001-007-002"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11418-020-01428-3","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T18:03:42Z","timestamp":1593453822000},"page":"741-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro"],"prefix":"10.1007","volume":"74","author":[{"given":"Zhijuan","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-0558","authenticated-orcid":false,"given":"Shu-zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"1428_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"1428_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.09.001","volume":"54","author":"SM Kazemi-Bajestani","year":"2016","unstructured":"Kazemi-Bajestani SM, Mazurak VC, Baracos V (2016) Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Semin Cell Dev Biol 54:2\u201310","journal-title":"Semin Cell Dev Biol"},{"key":"1428_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nature reviews Nat Rev Clin Oncol 10:90\u201399","journal-title":"Nature reviews Nat Rev Clin Oncol"},{"key":"1428_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14:754\u2013762","journal-title":"Nat Rev Cancer"},{"key":"1428_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-6147(96)10021-3","volume":"17","author":"JM Argil\u00e9s","year":"1996","unstructured":"Argil\u00e9s JM, L\u00f3pez-Soriano FJ (1996) The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci 17:223\u2013226","journal-title":"Trends Pharmacol Sci"},{"key":"1428_CR6","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","volume":"98","author":"MD Gomes","year":"2001","unstructured":"Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL (2001) Atrogin-1, A Muscle-Specific F-Box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98:14440\u201314445","journal-title":"Proc Natl Acad Sci USA"},{"key":"1428_CR7","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704\u20131708","journal-title":"Science"},{"key":"1428_CR8","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","volume":"71","author":"J Rodriguez","year":"2014","unstructured":"Rodriguez J, Vernus B, Chelh I (2014) Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways. Cell Mol Life Sci 71:4361\u20134371","journal-title":"Cell Mol Life Sci"},{"key":"1428_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrd4467","volume":"14","author":"S Cohen","year":"2015","unstructured":"Cohen S, Nathan JA, Goldberg AL (2015) Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 14:58\u201374","journal-title":"Nat Rev Drug Discov"},{"key":"1428_CR10","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","volume":"45","author":"HQ Han","year":"2013","unstructured":"Han HQ, Zhou X, Mitch WE, Goldberg AL (2013) Myostatin\/activin pathway antagonism: Molecular basis and therapeutic potential. Int J Biochem Cell Biol 45:2333\u20132347","journal-title":"Int J Biochem Cell Biol"},{"key":"1428_CR11","doi-asserted-by":"publisher","first-page":"R716","DOI":"10.1152\/ajpregu.00121.2011","volume":"301","author":"KT Murphy","year":"2011","unstructured":"Murphy KT, Chee A, Gleeson BG, Naim T, Swiderski K, Koopman R, Lynch GS (2011) Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Am J Physiol Regul Integr Comp Physiol 301:R716\u2013R726","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1428_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, Lacey DL, Goldberg AL, Han HQ (2010) Reversal of cancer cachexia and muscle wasting by actriib antagonism leads to prolonged survival. Cell 142:531\u2013543","journal-title":"Cell"},{"key":"1428_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-981-13-1435-3_8","volume":"1088","author":"WMH Hoogaars","year":"2018","unstructured":"Hoogaars WMH, Jaspers RT (2018) Past, present, and future perspective of targeting myostatin and related signaling pathways to counteract muscle atrophy. Adv Exp Med Biol 1088:153\u2013206","journal-title":"Adv Exp Med Biol"},{"key":"1428_CR14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/jcb.22098","volume":"106","author":"DH Lee","year":"2009","unstructured":"Lee DH, Szczepanski MJ, Lee YJ (2009) Magnolol induces apoptosis via inhibiting the EGFR\/PI3K\/Akt signaling pathway in human prostate cancer cells. J Cell Biochem 106:1113\u20131122","journal-title":"J Cell Biochem"},{"key":"1428_CR15","doi-asserted-by":"publisher","first-page":"E2362","DOI":"10.3390\/ijms19082362","volume":"19","author":"AM Ranaware","year":"2018","unstructured":"Ranaware AM, Banik K, Deshpande V, Padmavathi G, Roy NK, Sethi G, Fan L, Kumar AP, Kunnumakkara AB (2018) Magnolol: a neolignan from the magnolia family for the prevention and treatment of cancer. Int J Mol Sci 19:E2362","journal-title":"Int J Mol Sci"},{"key":"1428_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13395-019-0193-2","volume":"9","author":"D Liu","year":"2019","unstructured":"Liu D, Qiao X, Ge Z et al (2019) IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway. Skelet Muscle 9:8","journal-title":"Skelet Muscle"},{"key":"1428_CR17","doi-asserted-by":"publisher","first-page":"40235","DOI":"10.1074\/jbc.M004356200","volume":"275","author":"M Thomas","year":"2000","unstructured":"Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R (2000) Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275:40235\u201340243","journal-title":"J Biol Chem"},{"key":"1428_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/1087057113482585","volume":"18","author":"JN Cash","year":"2013","unstructured":"Cash JN, Angerman EB, Kirby RJ, Merck L, Seibel WL, Wortman MD, Papoian R, Nelson S, Thompson TB (2013) Development of a small-molecule screening method for inhibitors of cellular response to myostatin and activin a. J Biomol Screen 18:837\u2013844","journal-title":"J Biomol Screen"},{"key":"1428_CR19","first-page":"9681","volume":"15","author":"K Liao","year":"2018","unstructured":"Liao K, Yong CW, Hua K (2018) SB431542 inhibited cigarette smoke extract induced invasiveness of A549 cells via the TGF-\u03b21\/Smad2\/MMP3 pathway. Oncol Lett 15:9681\u20139686","journal-title":"Oncol Lett"},{"key":"1428_CR20","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","volume":"391","author":"ME Benny Klimek","year":"2010","unstructured":"Benny Klimek ME, Aydogdu T, Link MJ, Pons M, Koniaris LG, Zimmers TA (2010) Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun 391:1548\u20131554","journal-title":"Biochem Biophys Res Commun"},{"key":"1428_CR21","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","volume":"74","author":"YS Gallot","year":"2014","unstructured":"Gallot YS, Durieux AC, Castells J, Desgeorges MM, Vernus B, Plantureux L, R\u00e9mond D, Jahnke VE, Lefai E, Dardevet D, Nemoz G, Schaeffer L, Bonnieu A, Freyssenet DG (2014) Myostatin gene inactivation prevents skeletal muscle wasting in cancer. Can Res 74:7344\u20137356","journal-title":"Can Res"},{"key":"1428_CR22","doi-asserted-by":"publisher","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","volume":"296","author":"R Sartori","year":"2009","unstructured":"Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, Sandri M (2009) Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296:C1248\u2013C1257","journal-title":"Am J Physiol Cell Physiol"},{"key":"1428_CR23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD (2001) Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014\u20131019","journal-title":"Nat Cell Biol"},{"key":"1428_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5483\/BMBRep.2018.51.1.132","volume":"51","author":"SE Song","year":"2018","unstructured":"Song SE, Shin SK, Park SY, Hwang IS, Im SS, Bae JH, Choi MS, Song DK (2018) Epac2a-knockout mice are resistant to dexamethasone-induced skeletal muscle atrophy and short-term cold stress. BMB Rep 51:39\u201344","journal-title":"BMB Rep"},{"key":"1428_CR25","doi-asserted-by":"publisher","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","volume":"296","author":"AU Trendelenburg","year":"2009","unstructured":"Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ (2009) Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296:C1258\u2013C1270","journal-title":"Am J Physiol Cell Physiol"},{"key":"1428_CR26","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/ncomms7670","volume":"6","author":"G Milan","year":"2015","unstructured":"Milan G, Romanello V, Pescatore F, Armani A, Paik JH, Frasson L, Seydel A, Zhao J, Abraham R, Goldberg AL, Blaauw B, DePinho RA, Sandri M (2015) Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy. Nat Commun 6:6670","journal-title":"Nat Commun"},{"key":"1428_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","volume":"117","author":"M Sandri","year":"2004","unstructured":"Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399\u2013412","journal-title":"Cell"},{"key":"1428_CR28","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1152\/ajpcell.00114.2011","volume":"301","author":"S Lokireddy","year":"2011","unstructured":"Lokireddy S, Mouly V, Butler-Browne G, Gluckman PD, Sharma M, Kambadur R, McFarlane C (2011) Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Am J Physiol Cell Physiol 301:1316\u20131324","journal-title":"Am J Physiol Cell Physiol"},{"key":"1428_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.semcdb.2017.11.011","volume":"72","author":"PS Zammit","year":"2017","unstructured":"Zammit PS (2017) Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis. Semin Cell Dev Biol 72:19\u201332","journal-title":"Semin Cell Dev Biol"},{"key":"1428_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1152\/ajpcell.00012.2011","volume":"301","author":"C McFarlane","year":"2011","unstructured":"McFarlane C, Hui GZ, Amanda WZ, Lau HY, Lokireddy S, Xiaojia G, Mouly V, Butler-Browne G, Gluckman PD, Sharma M, Kambadur R (2011) Human myostatin negatively regulates human myoblast growth and differentiation. Am J Physiol Cell Physiol 301:195\u2013203","journal-title":"Am J Physiol Cell Physiol"},{"key":"1428_CR31","doi-asserted-by":"publisher","first-page":"49831","DOI":"10.1074\/jbc.M204291200","volume":"277","author":"B Langley","year":"2002","unstructured":"Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R (2002) Myostatin inhibits myoblast differentiation by down-regulating myod expression. J Biol Chem 277:49831\u201349840","journal-title":"J Biol Chem"},{"key":"1428_CR32","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/jcsm.12331","volume":"9","author":"T Golan","year":"2018","unstructured":"Golan T, Geva R, Richards D, Madhusudan S, Lin BK, Wang HT, Walgren RA, Stemmer SM (2018) LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial. J Cachexia Sarcopenia Muscle 9:871\u2013879","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-020-01428-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-020-01428-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-020-01428-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:51:03Z","timestamp":1624927863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-020-01428-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1428"],"URL":"https:\/\/doi.org\/10.1007\/s11418-020-01428-3","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"9 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicting interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}